Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BSX Q1 '25 Earnings Results & Recap

Boston Scientific posted Q1 adjusted EPS of $0.75, beating estimates of $0.67, and Q1 revenue of $4.57B exceeded estimates of $4.57B. The firm's full-year organic revenue growth guidance was raised to 12%-14%, while Q2 organic growth is expected to be 13%-15%.
9

Price since post

Full Details

Advertisement|Remove ads.